Investor centre

Latest documents

Form of Proxy for Use at Annual General Meeting
Notice of Annual General Meeting
Circular, Financing, October 2023

Analyst reports

New Trinity Delta Research Report – Ready to ROCK as RXC008 enters the clinic
New Trinity Delta Lighthouse Report – Up to $870m KRAS deal marks 3rd Jazz collaboration
New Trinity Delta Report – Anticipating Clinical Momentum and Catalysts in 2024

Investor FAQs

1. Where is the Company’s registered office?

Block 33, Mereside, Alderley Park, Macclesfield, SK10 4TG

2. How can I contact the company?

Please email us at info@redxpharma.com

3. What is the Company’s financial year end?

Our financial year ends on 30th September.

4. Are the Company’s shared listed?

Yes, our shares are listed on the AIM market. Operated by the London stock exchange.

5. How can I stay up-to-date with Company news?

Our website is updated frequently, and you can register for email alerts from within the investors section of our website.